Cargando…
COVID-19 and the antiphospholipid syndrome
Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic. Most COVID-19 patients are asymptomatic or have flu-like symptoms. However, around 15% of the patients may have severe disease, including unilateral or bilateral pneumonia with acute respiratory distress syndrome and progressive...
Autores principales: | Serrano, Manuel, Espinosa, Gerard, Serrano, Antonio, Cervera, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527199/ https://www.ncbi.nlm.nih.gov/pubmed/36195247 http://dx.doi.org/10.1016/j.autrev.2022.103206 |
Ejemplares similares
-
COVID-19 coagulopathy and antiphospholipid syndrome
por: Serrano, Manuel, et al.
Publicado: (2022) -
Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy
por: Serrano, Manuel, et al.
Publicado: (2022) -
Antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2008) -
Management of the antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2010) -
Editorial: Primary Antiphospholipid Syndrome
por: Serrano, Antonio, et al.
Publicado: (2020)